🇪🇺 Palbociclib in combination with AI in European Union

Palbociclib in combination with AI (palbociclib-in-combination-with-ai) regulatory status in European Union.

Marketing authorisation

EMA

  • Status: approved

Palbociclib in combination with AI in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in European Union

Frequently asked questions

Is Palbociclib in combination with AI approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Palbociclib in combination with AI in European Union?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.